e-learning
resources
Amsterdam 2015
Tuesday, 29.09.2015
Treatment and control of respiratory disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Can the influenza vaccine response be predicted in COPD patients by clinical parameters?
Tomas Mikal Eagan (Bergen, Norway), Tomas M.L. Eagan, Jon A. Hardie, åsne Jul-Larsen, Per S. Bakke, Rebecca J. Cox
Source:
International Congress 2015 – Treatment and control of respiratory disease
Session:
Treatment and control of respiratory disease
Session type:
Thematic Poster Session
Number:
4055
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Tomas Mikal Eagan (Bergen, Norway), Tomas M.L. Eagan, Jon A. Hardie, åsne Jul-Larsen, Per S. Bakke, Rebecca J. Cox. Can the influenza vaccine response be predicted in COPD patients by clinical parameters?. Eur Respir J 2015; 46: Suppl. 59, 4055
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
To code or not to code chronic pulmonary aspergillosis associated malnutrition in PMSI database: that is the problem…
Related content which might interest you:
Clinical efficacy of pneumococcal conjugate vaccine in patients with chronic airway disease
Source: International Congress 2014 – Clinical management of lung diseases: from bronchi to pleura
Year: 2014
Influenza vaccination in chronic asthma patients. Are more severely ill patients more likely to seek vaccination?
Source: Annual Congress 2013 –Viral infections
Year: 2013
Comparison of efficacy of grippe vaccination and broncho vaxom administration in COPD patients
Source: International Congress 2015 – Different data in COPD
Year: 2015
Clinical characteristics and risk factors of virus or influenza infection among the hospitalized pneumonia in COPD patients
Source: International Congress 2016 – Viral infections in different respiratory conditions: from the bedside to the lab
Year: 2016
Factors influencing on influenza vaccination among chronic obstructive pulmonary disease: The Korea national health and nutrition examination survey
Source: International Congress 2016 – COPD diagnosis and management
Year: 2016
Epidemiology of seasonal and pandemic influenza (H1N1) in German hospitals - Influence of comorbidity, ventilatory support and age on mortality
Source: International Congress 2014 – The epidemiology of respiratory infections and lung cancer
Year: 2014
Should chronic obstructive pulmonary disease patients must be vaccinated?
Source: Annual Congress 2013 –Lung infections: a clinical point of view
Year: 2013
Vaccination rates against pneumococcal and influenza infection in hospitalized cardiologic and pneumologic patients need to be improved.
Source: International Congress 2018 – Respiratory epidemiology: from infectious diseases to lung cancer
Year: 2018
Pneumococcal vaccination: Effects on exacerbation of COPD
Source: Annual Congress 2013 –COPD treatment
Year: 2013
Real-life effectiveness data on prevention OF COPD and asthma exacerbations with 13-valent pneumococcal conjugate vaccine (PCV13)
Source: International Congress 2016 – Microbiological issues and translational research in respiratory infections
Year: 2016
Pneumococcal vaccination coverage in Spanish patients with chronic obstructive pulmonary disease (COPD). Result of the EPIDEPOC study
Source: Eur Respir J 2004; 24: Suppl. 48, 144s
Year: 2004
Identification of nasal virus infection in patients with COPD exacerbations
Source: International Congress 2014 – COPD: points to ponder
Year: 2014
Compliance with the pneumococcal and influenza vaccination recommendations in patients with COPD in Catalonia (Spain)
Source: Eur Respir J 2005; 26: Suppl. 49, 594s
Year: 2005
Perception and uptake of the influenza and pneumococcal vaccinations in patients with COPD
Source: Annual Congress 2008 - Organisation of care and management of COPD
Year: 2008
Clinical efficacy of pneumococcal vaccine in COPD patients. preliminary results
Source: Eur Respir J 2003; 22: Suppl. 45, 408s
Year: 2003
Evolution of COPD phenotypes in time - Czech multicentre research database of severe COPD
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016
Influenza and pneumococcal vaccination in patients with COPD
Source: Virtual Congress 2020 – Pharmacological management of COPD
Year: 2020
Comparison of efficacy of grippe vaccination in asthma and COPD patients
Source: Annual Congress 2011 - Asthma: control and treatment
Year: 2011
Is clinical presentation different between men and women with COPD?
Source: International Congress 2014 – Clinical presentations
Year: 2014
Efficacy of influenza and pneumococcal vaccinations among patients with COPD
Source: Annual Congress 2007 - Treatment of COPD
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept